References
- 1. National Association for Proton Therapy. (2014). Retrieved August 20, 2014, from http://www.proton-therapy.org/facts.htm.
- 2. Fowler, J. F. (2003). What can we expect from dose escalation using proton beams. Clin. Oncol., 15(1), S10–S15. DOI: 10.1053/clon.2002.0182.
- 3. Xu, X. G., Bednarz, B., & Paganetti, H. (2008). A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys. Med. Biol., 53, 193–241. DOI: 10.1088/0031-9155/53/13/R01.
- 4. Chung, C. S., Keating, N., Yock, T., & Tarbell, N. (2008). Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int. J. Radiat. Oncol. Biol. Phys., 72(1), S8. DOI: 10.1016/j.ijrobp.2008.06.785.
- 5. Komaki, R., Sejpal, S., & Wei, X. (2008). Reduction of bone marrow suppression for patients with stage III NSCLC treated by proton and chemotherapy compared with IMRT and chemotherapy. Particle Therapy Cooperative Group 47, O10:14.
- 6. Mayahara, H., Murakami, M., Kagawa, K., Kawaguchi, A., Oda, Y., Miyawaki, D., Sasaki, R., Sugimura, K., & Hishikawa, Y. (2007). Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int. J. Radiat. Oncol. Biol. Phys., 69(2), 434–443. DOI: 10.1016/j.ijrobp.2007.03.009.
- 7. Steneker, M., Lomax, A., & Schneider, U. (2006). Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother. Oncol., 80(2), 263–267. DOI: 10.1016/j.radonc.2006.07.025.
- 8. Lee, C. T., Bilton, S. D., Famiglietti, R. M., Riley, B. A., Mahajan, A., Chang, E. L., Maor, M. H., Woo, S. Y., Cox, J. D., & Smith, A. R. (2005). Treatment planning with protons for pediatric retinoblasta, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int. J. Radiat. Oncol. Biol. Phys., 63(2), 362–372.
- 9. Miralbell, R., Lomax, A., Cella, L., & Scheider, U. (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys., 54(3), 824–829. DOI: 10.1016/S0360-3016(02)02982-6.
- 10. Michalec, B., Swakoń, J., Sowa, U., Ptaszkiewicz, M., Cywicka-Jakiel, T., & Olko, P. (2010). Proton radiotherapy facility for ocular tumors at the IFJ PAN in Krakow Poland. Appl. Radiat. Isot., 68(4/5), 738–742. DOI: 10.1016/j.apradiso.2009.11.001.
- 11. Swakon, J., Olko, P., Adamczyk, D., Cywicka-Jakiel, T., Dabrowska, J., Dulny, B., Grzanka, L., Horwacik, T., Kajdrowicz, T., Michalec, B., Nowak, T., Ptaszkiewicz, M., Sowa, U., Stolarczyk, L., & Waligorski, M. P. R. (2010). Facility for proton radiotherapy of eye cancer at IFJ PAN in Krakow. Radiat. Meas., 45(10), 1469–1471. DOI: 10.1016/j.radmeas.2010.06.020.
- 12. The Bronowice Cyclotron Centre, IFJ PAN. (2014). Retrieved August 20, 2014, from http://www.ifj.edu.pl/ccb/.
- 13. Brenner, D. J., & Hall, E. J. (2008). Secondary neutrons in clinical proton radiotherapy: A charged issue. Radiother. Oncol., 86, 165–170. DOI: 10.1016/j.radonc.2007.
- 14. Agosteo, S., Birattari, C., Caravaggio, M., Silari, M., & Tosi, G. (1998). Secondary neutron and photon dose in proton therapy. Radiother. Oncol., 48, 293–305. DOI: 10.1016/S0167-8140(98)00049-8.
- 15. Wroe, A., Rosenfeld, A., & Schulte, R. (2007). Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med. Phys., 34, 3449–3456.
- 16. Newhauser, W. D., Burns, J., & Smith, A. R. (2002). Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59. Med. Phys., 29, 1953–1961.
- 17. Yan, X., Titt, U., Koehler, A. M., & Newhauser, W. D. (2002). Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip., 476(1), 429–434. DOI: 10.1016/S0168-9002(01)01483-8.
- 18. International Commission on Radiation Units and Measurements. (1993). Quantities and units in radiation protection dosimetry. Bethesda, MD: ICRU. (ICRU Report 51).
- 19. International Commission on Radiation Units and Measurements. (2001). Determination of operational dose equivalent quantities for neutrons. ICRU Report 66, Journal of the ICRU, 1(2). Ashford, UK: Nuclear Technology Publishing.
- 20. Golnik, N. (1996). Recombination methods in the dosimetry of mixed radiation. Otwock-Świerk: Institute of Atomic Energy. (IAE-20/A).
- 21. Zielczynski, M., & Golnik, N. (1994). Recombination index of radiation quality – measuring and applications. Radiat. Prot. Dosim., 52, 419–422.
- 22. Zielczynski, M., Golnik, N., & Rusinowski, Z. (1996). A computer controlled ambient dose equivalent meter based on a recombination chamber. Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip., 370, 563–567. DOI: 10.1016/0168-9002(95)01013-0.
- 23. Golnik, N., Brede, H. J., & Guldbakke, S. (1997). Response of REM-2 recombination chamber to H*(10) of monoenergetic neutrons. Radiat. Prot. Dosim., 74, 139–144.
- 24. Zielczyński, M., Golnik, N., & Gryziński, M. A. (2008). Applications of recombination chambers in the dosimetry of high energy radiation fields. Nukleonika, 53(Suppl. 1), S45–S52.
- 25. Caresana, M., Denker, A., Esposito, A., Ferrarini, M., Golnik, N., Hohmann, E., Leuschner, A., Luszik-Bhadra, M., Manessi, G., Mayer, S., Ott, K., Röhrich, J., Silari, M., Trompier, F., Volnhals, M., & Wielunski, M. (2014). Intercomparison of radiation protection instrumentation in a pulsed neutron field. Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip., 737, 203–213. DOI: 10.1016/j.nima.2013.11.073.
- 26. Zielczyński, M., Golnik, N., & Gryziński, M. A. (2007). A comparison of different recombination methods in mixed radiation fields at high energy accelerators. Radiat. Prot. Dosim., 126(1/4), 248–252. DOI: 10.1093/rpd/ncm051.
- 27. Zielczyński, M., Golnik, N., Gryziński, M. A., & Tulik, P. (2010). The use of recombination chambers at radiation therapy facilities. Radiat. Meas., 45(10), 1472–1475. DOI: 10.1016/j.radmeas.2010.06.027.
- 28. Jakubowska, E., Zielczyński, M., Golnik, N., Gryziński, M. A., & Krzemiński, Ł. (2014). A ring-shaped recombination chamber for hadron therapy dosimetry. Radiat. Prot. Dosim. DOI: 10.1093/rpd/nct355.
- 29. Olsher, R. H., Hsu, H.-H., Beverding, A., Kleck, J. H., Casson, W. H., Vasilik, D. G., & Devine, R. T. (2000). WENDI: An improved neutron REM meter. Health Phys., 79(2), pdf only.
- 30. Olsher, R. H., & McLean, T. D. (2008). High-energy response of the PRESCILA and WENDI-II neutron rem meters. Radiat. Prot. Dosim., 130(4), 510–513. DOI: 10.1093/rpd/ncn092.
- 31. Cywicka-Jakiel, T., Stolarczyk, L., Swakoń, J., Olko, P., & Waligórski, M. P. R. (2010). Individual patient shielding for a proton eye therapy facility. Radiat. Meas., 45(10), 1127–1129. DOI: 10.1016/j.radmeas.2010.05.018.
- 32. European Commission Directorate-General for Energy and Transport. (2009). Directorate H – Nuclear Energy, Unit H.4 – Radiation Protection No. 160. Technical Recommendations for Monitoring Individuals Occupationally Exposed to External Radiation. Retrieved August 20, 2014, from http://ec.europa.eu/energy/nuclear/radiation_protection/doc/publication/160.pdf.